1-[[6-[2-ethyl-1-(1,2,4-triazol-4-yl)butyl]-1,3-benzothiazol-2-yl]oxymethyl]cycloheptane-1-carboxylic acid
C24H32N4O3S — CID 118873926
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[[6-[2-ethyl-1-(1,2,4-triazol-4-yl)butyl]-1,3-benzothiazol-2-yl]oxymethyl]cycloheptane-1-carboxylic acid
1-[[6-[2-ethyl-1-(1,2,4-triazol-4-yl)butyl]-1,3-benzothiazol-2-yl]oxymethyl]cycloheptane-1-carboxylic acid (PubChem CID 118873926) has the molecular formula C24H32N4O3S and a molecular weight of 456.61 g/mol. Its IUPAC name is 1-[[6-[2-ethyl-1-(1,2,4-triazol-4-yl)butyl]-1,3-benzothiazol-2-yl]oxymethyl]cycloheptane-1-carboxylic acid.
Molecular Properties
| Compound Name | 1-[[6-[2-ethyl-1-(1,2,4-triazol-4-yl)butyl]-1,3-benzothiazol-2-yl]oxymethyl]cycloheptane-1-carboxylic acid |
|---|---|
| PubChem CID | 118873926 |
| Molecular Formula | C24H32N4O3S |
| Molecular Weight | 456.61 g/mol |
| Exact Mass | 456.22 |
| IUPAC Name | 1-[[6-[2-ethyl-1-(1,2,4-triazol-4-yl)butyl]-1,3-benzothiazol-2-yl]oxymethyl]cycloheptane-1-carboxylic acid |
| SMILES | CCC(CC)C(c1ccc2nc(OCC3(C(=O)O)CCCCCC3)sc2c1)n1cnnc1 |
| InChI | InChI=1S/C24H32N4O3S/c1-3-17(4-2)21(28-15-25-26-16-28)18-9-10-19-20(13-18)32-23(27-19)31-14-24(22(29)30)11-7-5-6-8-12-24/h9-10,13,15-17,21H,3-8,11-12,14H2,1-2H3,(H,29,30) |
| InChIKey | YSKYUYMYMIBQTO-UHFFFAOYSA-N |
| XLogP | 5.72 |
| TPSA | 90.13 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 456.61 |
| LogP ≤ 5 | 5.72 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118873926 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.